Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Nan Hu Retires after 32 Years of Service

, by Jennifer K. Loukissas, M.P.P.

photograph of a woman seated

Dr. Nan Hu

Nan Hu, M.D., Ph.D., staff scientist in the Metabolic Epidemiology Branch (MEB), will retire from the National Cancer Institute in July 2024 after 32 years of service. Dr. Hu has integrated her training, experience, and skill in widely-varied but complementary disciplines—molecular genetics, bench work, epidemiologic field studies, and statistical analysis—to play a fundamental role in MEB’s research on the etiology, prevention, and early detection of upper gastrointestinal cancers.

Dr. Hu received her medical degree from the Shanxi Medical College in Taiyuan, China, in 1976, followed by a master’s degree in cytogenetics and medical genetics from the Beijing Medical College. After completing a doctorate in cancer genetics from the Peking Union Medical College under the mentorship of Dr. Wu Min, she served as a postdoctoral fellow with Dr. Janet Rowley at the University of Chicago before coming to the NCI, first as a visiting associate, and then as a postdoctoral fellow with Dr. Dean Hamer.

She joined the Cancer Prevention Fellowship program in 1994, earning an M.P.H. in epidemiology and biostatistics from the George Washington University in the process. Dr. Hu joined DCEG as a staff scientist and conducted research with several investigators, most recently in MEB. Working closely with Dr. Phil Taylor (DCEG retired) and Alisa M. Goldstein, Ph.D., senior investigator in the Clinical Genetics Branch, they completed very large-scale international multidisciplinary studies of esophageal and gastric cancer. This genetic-focused work included genome-wide association studies of esophageal squamous cell carcinoma, gastric cardia adenocarcinoma, and gastric noncardia adenocarcinoma as well seminal molecular genetics studies of these same tumors. Her work created a trove of biological samples that will be used for tumor sequencing studies for years to come. Most recently, she worked with a large international team to complete the first whole genome sequencing study of esophageal squamous dysplasia, the precursor lesion for ESCC.

Email